The COVID Project
The record
- Jurisdiction
- United States (federal); Drug Enforcement Administration, Diversion Control Division
- Level
- Federal
- Authority
- 21 U.S.C. 829(a); 21 C.F.R. 1306.12(b), 1306.04-.06
- Issued
- 2020-03-20 Mar. 20, 2020
- Effective
- 2020-03-20
- End
- For the duration of the public health emergency (read as 2021-09-30)
- In force
- Mar. 20, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Health care ordersOther
- Addressees
- the general public and the registrant community
- Functions reached
- CL clinical prescribing
- RT pharmacy dispensing
- CB patients
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
pursuant to 21 CFR 1306.12(b) an individual practitioner may issue multiple prescriptions authorizing the patient to receive a total of up to a 90-day supply of a schedule II controlled substance, subject to specific conditions... Subject to the provisions of 21 CFR 1306.06... and if the prescription meets the requirements of 21 CFR 1306.04(a), this practice may be permitted if the early dispensing is allowed by state law and regulation.
Enforcement
Interpretation governing pharmacy dispensing under 21 U.S.C. 829
Notes
Reached pharmacies and prescribers whose patients sought extended supplies under stay-at-home orders.
Retrieval noteDigitally signed Mar. 21, 2020.